Affiliation:
1. Division of Virology, ICMR-National AIDS Research Institute, Pune 411026, Maharashtra, India
2. Molecular Biology, National
AIDS Research Institute, Pune 411026, India
Abstract
Introduction:
The monkeypox virus has emerged as an uncommon zoonotic infection. The recent
outbreak of MPXV in Europe and abroad in 2022 presented a major threat to individuals at risk. At present, no
specific MPXV vaccinations or medications are available.
Methods:
In this study, we predicted the most effective siRNA against the conserved region of the MPXV and
validated the activity by performing molecular docking studies.
Results:
Ultimately, the most efficient siRNA molecule was shortlisted against the envelope protein gene
(B6R) based on its toxicity, effectivity, thermodynamic stability, molecular interaction, and molecular dynamics
simulations (MD) with the Human Argonaute 2 protein.
Conclusion:
Thus, the strategy may offer a platform for the development of potential antiviral RNA therapeutics
that target MPXV at the genomic level.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology